(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
4 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 6.60%
Live Chart Being Loaded With Signals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug...
Stats | |
---|---|
Šios dienos apimtis | 26 194.00 |
Vidutinė apimtis | 45 775.00 |
Rinkos kapitalizacija | 215.00M |
EPS | $0.400 ( 2024-03-15 ) |
Kita pelno data | ( $0.193 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 8.14 |
ATR14 | $0.0460 (0.51%) |
Cipher Pharmaceuticals Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
ATD.TO | 0.901 |
RQL.TO | 0.886 |
CCO.TO | 0.87 |
BDT.TO | 0.865 |
PKI.TO | 0.863 |
BDI.TO | 0.863 |
RQN.TO | 0.857 |
CMG.TO | 0.857 |
SNC.TO | 0.837 |
THNC.TO | 0.832 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
HOT-UN.TO | -0.899 |
GEO.TO | -0.858 |
LGO.TO | -0.857 |
WEF.TO | -0.852 |
PLRB.V | -0.852 |
HEXO.TO | -0.838 |
BYL.TO | -0.835 |
CRRX.TO | -0.831 |
FIL.TO | -0.831 |
S.TO | -0.827 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Cipher Pharmaceuticals Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $21.16M |
Bruto pelnas: | $17.09M (80.77 %) |
EPS: | $0.820 |
FY | 2023 |
Pajamos: | $21.16M |
Bruto pelnas: | $17.09M (80.77 %) |
EPS: | $0.820 |
FY | 2022 |
Pajamos: | $20.68M |
Bruto pelnas: | $16.68M (80.69 %) |
EPS: | $0.250 |
FY | 2021 |
Pajamos: | $21.94M |
Bruto pelnas: | $18.26M (83.21 %) |
EPS: | $0.0740 |
Financial Reports:
No articles found.
Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.